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Abstract
Structurally diverse secondary amine-functionalized poly(propylene imine) (PPI) dendrimers
capable of tunable nitric oxide (NO) release were synthesized in a straightforward, one-step
manner using ring-opening or conjugate-addition reactions with propylene oxide (PO), styrene
oxide (SO), acrylonitrile (ACN), poly(ethylene glycol) methyl ether acrylate (average Mn = 480)
(PEG) or 1,2-epoxy-9-decene (ED). N-Diazeniumdiolate nitric oxide donors were formed on the
resulting secondary amine-functionalized G2–G5 PPI dendrimers by reaction with NO gas in basic
solution. The NO storage and release kinetics for the resulting dendritic scaffolds were diverse
(0.9–3.8 μmol NO/mg totals and 0.3 to 4.9 h half lives), illustrating the importance of the exterior
chemical modification (e.g., steric environments, hydrophobicity, etc.) on diazeniumdiolate
stability/decomposition. Tunable NO release was demonstrated by combining two donor systems
on the exterior of one macromolecular scaffold. Additionally, a mathematical model was
developed that allows for the simulation of dual NO release kinetics using the NO release data
from the two single NO donor systems. The approaches described herein extend the range and
scope of NO-releasing macromolecular scaffolds by unlocking a series of materials for use as
dopants in biomedical polymers or stand-alone therapeutics depending on the exterior
modification.
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Introduction
Dendrimers are a family of hyperbranched macromolecules with multivalent surfaces that
enable the design of targeted therapeutics agent delivery vehicles.1–4 For example,
polyamidoamines,5 polyamines,6 polypeptides,7 polyesters8 and polyethers9 dendrimers
have been utilized for a range of biomedical applications, including drug and gene
delivery,10–22 biological imaging,23–29 and tissue engineering.30–33 Bactericidal dendrimers
have been prepared by encapsulating antibacterial agents (e.g., sulfomethoxazole34) within
the dendrimer or at its periphery (e.g., quaternary ammonium groups35). Anionic
amphiphilic dendrimers were also reported to possess antibacterial efficacy against Gram-
positive bacteria.36
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Nitric oxide is an endogenously produced diatomic free radical that mediates multiple
processes in mammalian physiology. Due to NO’s pharmacological potential, the synthesis
of prodrugs capable of controlled exogeneous NO production is important in further
understanding NO’s role in physiology and developing NO-based therapeutics. The
therapeutic effectiveness of such donors depends on the target (e.g., cell type and condition),
concentration and rate of NO release.37, 38 For example, Chakrapani and coworkers
synthesized O2-(2,4-dinitro-5-(4-(N-methylamino) benzoyloxy)phenyl)-1-(N,N-
dimethylamino)diazen-1-ium-1,2-diolate (PABA/NO) as an anti-cancer NO prodrug with
efficacy against human leukemia and A2780 human ovarian cancer xenografts.39 Both the
NO payload and release kinetics were shown to influence the anticancer activity. The study
of how chemical structure impacts the rate of NO release from small molecule NO donors
has been an active area of research, particularly with respect to biological activity.40–45
Generally, stabilization of the N-diazeniumdiolate NO donor correlates directly with
extended NO release.46
To enhance NO storage and release levels relative to small molecule NO donors, we
previously reported the synthesis of N-diazeniumdiolate-functionalized poly(propylene
imine) (PPI) dendrimer conjugates as macromolecular NO donors capable of storing up to
~5 μmol NO/mg with NO release kinetics dependent on the dendrimer structure.47 Although
we alluded to the multivalent exterior benefit on NO storage/release and further
functionalization for imaging, controlled toxicity, and/or active targeting, for example, the
study of structure/nitric oxide release relationships was not systematically pursued. In
subsequent work, Stasko et al. reported the synthesis of S-nitrosothiol-modified
polyamidoamine (PAMAM) dendrimers with alternative decomposition mechanisms for
controlled NO release.48 While capable of storing ~2 μmol NO/mg, the kinetics of NO
release were found to be highly dependent on the structure of the nitrosothiol and NO
release trigger (e.g., light, copper, temperature). Collectively, the dendritic effects exerted on
NO donor stability and reactivity, and the benefits of multi-functionalization with imaging
beacons and/or active targeting agents, highlight the tremendous potential of dendrimers as
NO release therapeutics.
Herein, we describe the synthesis of N-diazeniumdiolate-functionalized PPI dendrimers
using select exterior functionalities to diversify both the NO release kinetics and potential
applications for which such materials may prove useful. In addition to assessing the roles of
molecular weight (e.g., generation or size of dendrimer) and exterior chemical structure on
NO release, we demonstrate the ability to tune NO release kinetics using multiple NO donor
functionalization.
Experimental Section
Materials and General Considerations
Details of the synthesis of primary amine-functionalized PPI dendrimers (G1 to G5-PPI-
NH2) are provided as Supporting Information. Ethylenediamine (EDA), acrylonitrile (ACN),
propylene oxide (PO), styrene oxide (SO), poly(ethylene glycol) methyl ether acrylate
(average Mn = 480) (PEG), and 1,2-epoxy-9-decene (ED) were purchased from Aldrich
Chemical Company (Milwaukee, WI). 1,6-Hexanediamine (HDA) and sodium methoxide
(5.4 M solution in methanol) was purchased from Acros Organics (Geel, Belgium). Sponge
cobalt catalyst (A-8B46) was purchased from Johson Matthey Catalysts (London, UK).
Common laboratory salts and solvents were purchased from Fisher Scientific (Pittsburgh,
PA). All other materials were used as received without further purification unless otherwise
noted. 1H nuclear magnetic resonance (NMR) spectra were recorded on Bruker (400 MHz)
and Varian (600 MHz) spectrometers. Hydrogenation reactions used for the synthesis of
PPI-NH2 (e.g., from G2 to G5) were carried out in a stainless steel high-pressure reactor
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purchased from Parr Instrument Company (Moline, IL). Agitation was provided by a
Teflon-coated magnetic stirring bar. Heating was provided using a heating fabric wrapped
around the reactor, and temperature was controlled using a temperature controller via a
thermal coupler. Nitric oxide release was measured using Sievers 280i Chemiluminesce
Nitric Oxide Analyzer (Boulder, CO) as described previously.47 The chemiluminescence
analyzer was calibrated with NO gas (26.9 ppm). A parameter for converting the instrument
response (ppb) to moles of NO was obtained using the conversion of nitrite standards to NO
in a 0.1 M KOH/H2SO4 solution (1.31 × 10−13 moles NO/ppb).
Synthesis of Secondary Amine-Functionalized PPI Dendrimers
100 mg PPI-NH2 (e.g., from G2 to G5) was dissolved in 2 ml methanol in a 10ml vial. One
equivalent of acrylonitrile (ACN), poly(ethylene glycol) methyl ether acrylate (average Mn
= 480) (PEG), propylene oxide (PO), styrene oxide (SO), or 1,2-epoxy-9-decene (ED) (e.g.,
with respect to molar amount of primary amine functionality) was then added to the 10 mL
vial. The solution was stirred at room temperature for 4 d. Solvent was removed under
reduced pressure. Dendrimers were dissolved in water followed by dialysis against water
and lyophilization.
Representative 1HNMR data of secondary amine-functionalized G5-PPI conjugate formed
via the reactions of G5-PPI-NH2 with ACN, PEG, PO, SO, and ED (referred to hereafter as
G5-PPI-ACN a-64, G5-PPI-PEG b-64, G5-PPI-PO c-64, G5-PPI-SO d-64, G5-PPI-ED
e-64) are as follows: G5-PPI-ACN a-64: 1H NMR (400 MHz, CD3OD, δ): 2.87
(NHCH2CH2CN), 2.82 (NHCH2CH2CN), 2.60 (NCH2CH2CH2NH), 2.40
(NCH2CH2CH2NH), 1.60 (NCH2CH2CH2NH). 13C NMR (400 MHz, CD3OD, δ): 117,
52.4, 51.8, 44.5, 33.3, 26.1, 23.6, 16.9. G5-PPI-PEG b-64: 1H NMR (400 MHz, CD3OD, δ):
2.60 (NCH2CH2CH2NH), 2.40 (NCH2CH2CH2NH), 1.60 (NCH2CH2CH2NH), 3.40–3.70
(OCH2CH2O), 2.80 (CH2NHCH2CHCOOPEG), 2.65 (CH2NHCH2CHCOOPEG), 2.42
(CH2NHCH2CHCOOPEG). 13C NMR (400 MHz, CD3OD, δ): 172, 71.6, 70.85, 69.3, 60.1,
57.0, 51.4, 43.9, 39.1, 22.9. G5-PPI-PO c-64: 1H NMR (400 MHz, CD3OD, δ): 3.70
(CH2CH(OH)CH3), 2.60–2.62 (CH2CH(OH)CH3, NCH2CH2CH2NH), 2.40
(NCH2CH2CH2NH), 1.60 (NCH2CH2CH2NH), 1.00 (CH2CH(OH)CH3). 13C NMR (400
MHz, CD3OD, δ): 66.9, 58.2, 53.7, 52.8, 41.2, 30.8, 27.6, 24.9, 21.8. G5-PPI-SO d-64: 1H
NMR (400 MHz, CD3OD, δ): 7.50–7.20 (CH2CH(OH)Ph), 3.70 (CH2CH(OH)Ph), 2.72
(CH2CH(OH)Ph), 2.60 (NCH2CH2CH2NH), 2.40 (NCH2CH2CH2NH), 1.60
(NCH2CH2CH2NH). 13C NMR (400 MHz, CD3OD, δ): 140.6, 128.2, 127.5, 127.3, 125.8,
71.9, 57.1, 52.4, 45.6, 39.8, 26.3, 23.6. G5-PPI-ED e-64: 1H NMR (400 MHz, CD3OD, δ):
5.74 (CH2CH=CH2), 4.88 (CH2CH=CH2), 3.58 (NHCH2CH(OH)CH2), 2.60
(NCH2CH2CH2NH), 2.40 (NCH2CH2CH2NH), 1.98 (CH2CH=CH2), 1.60
(NCH2CH2CH2NH), 1.2–1.4 ((CH2)5CH2CH=CH2 ). 13C NMR (400 MHz, CD3OD, δ):
140.0, 116.1, 70.5, 56.5, 52.4, 47.2, 39.2, 33.9, 30.2, 25.6, 24.9.
Synthesis of Diazeniumdiolate-Functionalized PPI Dendrimers
One equivalent of 5.4 M sodium methoxide solution in methanol (e.g., with respect to the
molar amount of primary amine functionalities in PPI-NH2 used to synthesize these
secondary amine-functionalized PPI) was added to a vial containing G1 to G5 secondary
amine-functionalized PPI dendrimers in methanol (2 mL), The resulting reaction solution
was charged with 10 atm of NO while stirring in a stainless steel reactor. Prior to charging
with NO, the reactor was flushed three times with argon followed by a series of three longer
charge/discharge cycles with argon (3 × 10 min) to remove oxygen from the stirring
solutions. The reactor was then filled with 10 atm of NO (purified over KOH pellets for 30
min to remove trace NO degradation products) at ambient temperature. After 3 days, the NO
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was expunged using the same charge/discharge procedures described above with argon to
remove unreacted NO from the reaction solution.
Characterization of NO Storage and Release
Aliquots (~10–25 μL) of diazeniumdiolate-functionalized PPI as a solution in methanol
(e.g., ~7–200 mM) were added to 30 mL deoxygenated phosphate buffered saline (PBS) (10
mM, pH = 7.4) at 37 °C to initiate NO release. Nitrogen was flowed through the solution at
a flow rate of 70 mL/min to carry the liberated NO to the analyzer. Additional nitrogen flow
was supplied to the flask to match the collection rate of the instrument at 200 mL/min. Nitric
oxide analysis was terminated when levels decreased to 10 ppb NO/mg dendrimer.
Chemiluminescence data for the NO-releasing dendrimers were represented as: i) total
amount of NO release (t[NO], μmol NO/mg and μmol NO/μmol of secondary amine-
functionalized dendrimers); ii) maximum flux of NO release ([NO]max, ppb/mg of secondary
amine-functionalized dendrimers); iii) half-life (t1/2) of NO release; and, iv) conversion
efficiency defined as percentages of amine functionalities in PPI (e.g., from G1 to G5)
converted to diazeniumdiolate functionality (e.g., total moles of NO release divided by twice
the molar amount of primary amine functionalities in PPI-NH2 used initially to synthesize
secondary amine-functionalized dendrimer conjugates).
Results and Discussion
Synthesis and Characterization of Secondary Amine-Functionalized PPI Dendrimers
Stasko et al. previously reported an approach whereby secondary amine-functionalized PPI
conjugates were reacted with NO at high pressure to form NO-releasing dendritic scaffolds
with large NO storage capacity47. Analogously, primary amine-functionalized PPI
dendrimers were characterized by significantly less NO storage and shorter NO release
durations. These results suggest that the structural features of the dendrimer are critical in
the design of diazeniumdiolate-functionalized scaffolds. Since chemical reaction of primary
amine functionalities with organic compounds represents a simple approach for designing
secondary amine-functionalized PPI conjugates, we targeted the synthesis of secondary
amine-functionalized dendrimers using ring-opening and conjugate-addition reactions of
PPI-NH2 with PO, SO, ED, ACN, and PEG (Scheme 1) to fully unlock a series of dendrimer
scaffolds with diverse exterior properties (e.g., aromatic, hydrophilic, hydrophobic). Indeed,
the epoxides, acrylated and acrylonitrile selected for conjugation were based on sterics,
hydrophobicity, and biocompatibility. Of note, it is also possible to yield tertiary amine
adducts. In addition, we carried out a series of model kinetic studies using NMR
spectroscopy for conjugate-addition reactions of first generation G1-PPI-NH2 with ACN and
ring-opening reactions of HDA with PO to determine the suitability of conjugate-addition
and ring-opening reactions for the synthesis of secondary amine-functionalized PPI
dendrimers. The results of these studies revealed large differences in the rates of reactions of
G1-PPI-NH2 with ACN, and HDA with PO. The rate constants of the first conjugate-
addition or ring-opening reaction (k1) were substantially larger than those of the second
reactions (k2) (data not shown), providing strong support for the use of such reactions (e.g.,
over a period of four days, in a dilute solution, and at one equivalent of ACN, epoxides, or
acrylates with respect to molar amount of PPI-NH2) to yield secondary amine-functionalized
products suitable for subsequent NO release studies.
Influence of Exterior Functionality on Nitric Oxide Release
The approach described above is based on dendrimer functionalization at their exterior to
yield secondary amine-functionalized PPI dendrimers. Two practical advantages of this
approach include that the synthesis is simple and the resulting structurally diverse exteriors
greatly expand the potential applications for which these materials may find utility.
Lu et al. Page 4













Reactions of secondary amine-functionalized PPI (e.g., from G2 to G5) with NO under basic
conditions (e.g., sodium methoxide) yielded N-diazeniumdiolate NO donor-functionalized
dendrimers with diverse NO release characteristics.
Chemiluminescence was used to characterize the NO storage and release properties (e.g., in
PBS, pH = 7.4, 37 °C) for the N-diazenuimdiolate-modified PPI dendrimers. Representative
NO release profiles for these dendrimers are shown in Figure 1. The workup of specific NO
release parameters (e.g., total NO release, maximum flux, half-life, and conversion
efficiency) are provided in Table 1. In general, the NO release results reveal high NO
storage capabilities (e.g., 0.9–3.8 μmol NO/mg) and a broad range of release kinetics (e.g.,
NO release half-life from 0.3–4.9 h). Further inspection of these data reveals that the
conversion efficiencies (e.g., 10–40%) of the dendrimers varied substantially based on the
chemical modification. As shown in Table 1, G2 to G5-PPI-SO (d-NO) were characterized
by lower NO donor formation (e.g., ~10–15%) versus the other PPI dendrimers (e.g., ~14–
40%). The lower conversion efficiencies for PPI-SO (d-NO) may be attributed to a more
sterically-hindered environment around the NO donor precursors (i.e., secondary amines),
resulting in lower NO and base accessibility to the amines during the NO charging process.
The exterior modification also influenced the NO release kinetics. For example, both PPI-
PO (c-NO) and PPI-PEG (b-NO) released NO rapidly (Table 1 and Figure 1). Such rapid
NO release kinetics might be expected since the isopropyl and PEG groups are hydrophilic
and facilitate water solvation favorable to diazeniumdiolate NO donor degradation. The data
also indicate that the NO release half-lives for G2-G5 PPI-SO (d-NO) and PPI-ED (e-NO)
are slightly longer than PPI-PO (c-NO) and PPI-PEG (b-NO). The longer NO release for
PPI-SO (d-NO) and PPI-ED (e-NO) correlates well with the increased hydrophobic
structure at the exteriors of these dendrimers.
The ACN modification for PPI dendrimer (a-NO) exhibited large NO storage (e.g., ~1.7–3.6
μmol NO/mg) and conversion efficiency (e.g., ~14–26%) (Table 1). Of note, past studies
have indicated that the reaction of cyano-containing compounds with NO at high-pressures
under basic conditions may yield C-diazeniumdiolate-functionalized products. Both NO and
nitrous oxide (N2O) may be release from C-diazeniumdiolates in aqueous environments at
low pH.49–51 In this context, it may be possible that the high conversion efficiencies for PPI-
ACN (a-NO) arise from the contribution of NO released from C-diazeniumdiolate-
functionalized products. A series of experiments were thus carried out to probe the nature of
the NO release from PPI-ACN (a-NO) using G0.5-PPI, a cyano-containing compound
without the capacity to form N-diazeniumdiolate due to the absence of secondary amines.
The NO release from G0.5-PPI was ~4.5×10−3 μmol NO/mg, providing strong support that
the high NO storage and conversion efficiency for the ACN-modified dendrimers are indeed
the result of N-diazeniumdiolate functionalization.
The PPI-ACN (a-NO) analogues were also characterized as having the longest NO release
half-lives (e.g., ~5 h). Given the hydrophilic nature of the cyano functionality, the extended
NO release is not attributable to water uptake. For example, the long half-lives of N-
diazeniumdiolate- functionalized small molecule derivatives (e.g., dipropylenetriamine or
DPTA-NO) have previously been attributed to diazeniumdiolate stabilization by neighboring
cationic ammonium functionalities as depicted in Figure 2A.45,52,53 In this manner, the
presence of neighboring cationic functionalities (e.g., protonated imidates) for PPI-ACN (a-
NO) dendrimers may provide additional stabilization to the diazeniumdiolate functionality
(Figure 2B).
Since sodium methoxide was used as the base for the reaction of PPI-ACN (a) with NO (to
yield diazeniumdiloate-functionalized products), the methoxide anion may also serve as a
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nucleophile to react with the cyano group in PPI-ACN (a) and yield imidate adducts.54 The
transfer of proton from solvent (e.g., methanol) to the relatively basic nitrogen atom in the
resulting imidates might thus lead to protonated-imidate functionality (Figure 2B) that is
similar to cationic ammonium functionality in DPTA-NO (Figure 2A).
As shown in Table 1, both the NO storage and maximum NO flux per dendrimer molecule
increased as a function of dendrimer size (i.e., generation). For example, the NO payload
from G5-PPI-PO-NO (c-64-NO) was 41.1 μmol/μmol dendrimer, much greater than G2-
PPI-PO-NO (c-8-NO) (e.g., 3.63 μmol/μmol dendrimer). A similar trend is observed for
maximum NO flux. These results reveal the capability of larger NO-releasing PPI
dendrimers to deliver significant concentrations of NO, a potentially beneficial attribute for
therapeutic anti-microbial and anti-cancer applications.
Effect of Solvent for NO Conjugation
As synthesized, the amphiphilic secondary amine-functionalized dendrimers (e.g., PPI-SO,
PPI-ED) possess a hydrophilic PPI core and hydrophobic periphery of aromatic rings or long
alkyl chains. Different from PPI-ACN, PPI-PO and PPI-PEG, these amphiphilic dendrimers
may have more packed exterior in the charging solvent due to the poor compatibility of the
aromatic rings or long alkyl chains with polar solvent (e.g., methanol). We thus sought to
investigate the role of charging solvent on NO donor formation efficiency using mixtures of
methanol with less polar solvent (e.g., methanol/THF (9:1, v/v), methanol/toluene (9:1, v/v)
and methanol/toluene (1:1, v/v)). As shown in Figure 3, the NO release data reveals an
adverse effect of toluene and THF on NO conjugation to PPI-SO dendrimers. Compared to
toluene, use of THF compromised the NO storage to a larger extent.
The lower NO conjugation efficiency may be the result of the PPI dendrimer core collapsing
in the mixture of methanol and less polar solvents (e.g., toluene and THF). Indeed, this
hypothesis is supported by dynamic light scattering data (data not shown). In turn, the
dendrimer backbone collapse likely contributes to a greater steric hindrance around the
secondary amines and concomitant lower NO conjugation efficiency.
Characterization of PPI Conjugates Synthesized from Defined Mixtures of PO and ACN
To evaluate the ability to define NO release, we designed multi-functionalized N-
diazeniumdiolate- functionalized dendrimer conjugates using G5-PPI-NH2 and defined
ratios of PO and/or ACN during the functionalization step. Specifically, G5-PPI-NH2 was
reacted with either PO exclusively (e.g., c-64), ACN exclusively (e.g., a-64), or three
different mixtures comprised of PO and ACN at molar ratios of 3:7, 5:5, and 7:3,
respectively; the PO, ACN, or defined mixtures of PO and ACN were one equivalent with
respect to molar amount of primary amine functionalities in G5-PPI-NH2. A series of 1H
NMR experiments were carried out on the products of these reactions to determine the
actual compositions of PO and ACN conjugated to the G5-PPI-NH2 (Figure 4). A distinct
resonance at 1.10 ppm was apparent corresponding to the methyl protons in the isopropyl
group of the products. The chemical shift of this peak was noted in the products for reactions
with PO exclusively (e.g., c-64) and those with different mixtures of PO and ACN. Further
inspection of these data indicates the presence of a second distinct peak at 2.80 ppm, formed
upon G5-PPI-NH2 dendrimer reaction with either ACN exclusively (e.g., a-64) or defined
mixtures of PO and ACN; this peak corresponds to the methylene protons one carbon away
from the cyano group of the products. The compositions of PO and ACN incorporated in the
products were 27/73 (c/a (27/73)), 40/60 (c/a (40/60)), and 60/40 (c/a (60/40)), and indicate
that the ACN was incorporated at ratios greater than that in the reaction mixtures likely due
to more rapid reaction of G5-PPI-NH2 with ACN versus PO.
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The NO release from the G5-PPI-PO/ACN conjugates at PO/ACN molar ratios of 27/73,
40/60, and 60/40, respectively, were intermediate to those synthesized based upon G5-PPI-
NH2 reactions with either PO (e.g., c-64) or ACN (e.g., a-64) alone. Furthermore, the NO
release profiles were influenced by the molar ratio of PO/ACN composition. For instance,
the NO release was prolonged for the PPI conjugates modified with lower molar ratio of PO/
ACN (half-lives of 2.90, 1.57, and 1.10 h for 27/73, 40/60, and 60/40, respectively) (Figure
5).
A mathematical model was developed to predict the NO release from hybrid G5-PPI-PO/
ACN conjugates using the NO release data from the single G5-PPI-PO (c-64) and G5-PPI-
ACN (a-64) systems. In Equation 1, a:b is the molar ratio of the PO and ACN modification
in the hybrid G5-PPI-PO/ACN conjugate as determined by NMR spectroscopy, while yPO
and yACN represent the normalized NO release profiles of the G5-PPI-PO (c-64) and G5-
PPI-ACN (a-64) systems, respectively. Simulated NO release from a hybrid G5-PPI-PO/
ACN conjugate (ya:b) was thus derived by averaging the normalized NO release from G5-
PPI-PO (c-64) (yPO) and G5-PPI-ACN (a-64) (yACN) weighted with respect to the mole
percentages of PO (i.e., [a/(a+b)] × 100%) and ACN (i.e., [b/(a+b)] × 100%) modification in
the hybrid G5-PPI-PO/ACN conjugate.
Eq.1
As shown in Figure 5, the simulated NO release from G5-PPI-PO/ACN conjugates were
comparable with the experimental data, even though the experimental hybrid PPI conjugates
were characterized by slightly faster NO release (e.g., NO release half-lives of 3.13, 2.42,
and 1.65 h for c/a (27/73), c/a (40/60), and c/a (60/40), respectively). Nevertheless, the
developed mathematical model appears to be well suited for simulating dual NO release
kinetics using NO release data from single NO donor systems. For dendrimers, these results
demonstrate that functionalization of PPI-NH2 with a defined mixture of PO and ACN
allows for precise NO release selection with access to NO release kinetics that are
intermediate to those formed upon reactions with one NO donor type exclusively.
Conclusions
To expand the utility of macromolecular NO-release scaffolds as stand-alone therapeutics,
dopants for biomedical polymers, or general NO-release sources, we synthesized a series of
diverse NO-releasing PPI dendrimers by straightforward chemical modification of the core
dendrimer using conjugation addition (ACN and PEG) or ring opening (PO, ED, and SO)
reactions. The NO release from these resulting dendrimers demonstrated that size (i.e.,
generation number or molecular weight) and exterior structures (e.g., steric environment,
hydrophobicity, etc.) play important roles in NO release kinetics. Furthermore, the use of
select NO donors with unique NO release kinetics and overall payloads may be exploited by
multi-NO donor/dendrimer functionalization. The combination of structural diversity and
achievable NO release (i.e., up to 3.8 μmol NO/mg with half-lives from 0.3–4.9 h) should
prove useful in the further study and utilization of these NO release materials for a broad
range of fundamental and applied applications including pharmacological agents.
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(A) Real time NO release profile for NO-releasing G4-PPI dendrimer conjugates; and (B)
plot of t[NO] vs time for NO-releasing PPI dendrimer conjugates.
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Proposed structures for stabilization of (A) diazeniumdiolate-functionalized DPTA by
neighboring cationic ammonium functionality, and (B) PPI-ACN (a-NO) by neighboring
cationic protonated-imidate functionality.
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(A) Real time NO release profile and (B) plot of t[NO] vs time for G4-PPI-SO-NO
synthesized in different NO conjugation solvents.
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1H NMR spectra of G5-PPI-PO (c-64) (A), G5-PPI-ACN (a-64) (E), G5-PPI-PO/ACN at
molar ratios of 7:3 (B), 5:5 (C), and 3:7 (D). The actual compositions of PO and ACN
incorporated into these three PPI conjugates are at molar ratios of 27/73 (B), 40/60 (C), and
60/40 (D), respectively, as determined by integrating two chemical shifts at 1.10 and 2.80
ppm.
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(A) Experimental plot of percent total NO released in PBS (pH = 7.4) at 37 °C as a function
of time for G5-PPI-PO (c-NO), G5-PPI-ACN (a-NO), and G5-PPI-PO/ACN conjugates; (B)
Simulated plot of percent total NO released for G5-PPI-PO/ACN conjugates.
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Synthesis of secondary amine- and diazeniumdiolate-functionalized PPI conjugates for
which n represents the number of primary amines on the periphery of PPI dendrimers (n = 8,
16, 32, 64).
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